In particular, in BRCA1 mutation carriers, the cumulative life time risk for breast cancer is about 70%; for ovarian cancer 40%; and, in BRCA2 mutation carriers, 50% for breast and 10% for ovarian cancer. This evidence concerns the gene BRCA2 and ovarian cancer.